This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slayden, R. A.
Right arrow Articles by Besra, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slayden, R. A.
Right arrow Articles by Besra, G. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 12 1996, 2813-2819, Vol 40, No. 12
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis

RA Slayden, RE Lee, JW Armour, AM Cooper, IM Orme, PJ Brennan and GS Besra
Department of Microbiology, Colorado State University, Fort Collins 80523-1677, USA.

Thiolactomycin (TLM) possesses in vivo antimycobacterial activity against the saprophytic strain Mycobacterium smegmatis mc2155 and the virulent strain M. tuberculosis Erdman, resulting in complete inhibition of growth on solid media at 75 and 25 micrograms/ml, respectively. Use of an in vitro murine macrophage model also demonstrated the killing of viable intracellular M. tuberculosis in a dose-dependent manner. Through the use of in vivo [1,2-14C]acetate labeling of M. smegmatis, TLM was shown to inhibit the synthesis of both fatty acids and mycolic acids. However, synthesis of the shorter- chain alpha'-mycolates of M. smegmatis was not inhibited by TLM, whereas synthesis of the characteristic longer-chain alpha-mycolates and epoxymycolates was almost completely inhibited at 75 micrograms/ml. The use of M. smegmatis cell extracts demonstrated that TLM specifically inhibited the mycobacterial acyl carrier protein-dependent type II fatty acid synthase (FAS-II) but not the multifunctional type I fatty acid synthase (FAS-I). In addition, selective inhibition of long- chain mycolate synthesis by TLM was demonstrated in a dose-response manner in purified, cell wall-containing extracts of M. smegmatis cells. The in vivo and in vitro data and knowledge of the mechanism of TLM resistance in Escherichia coli suggest that two distinct TLM targets exist in mycobacteria, the beta-ketoacyl-acyl carrier protein synthases involved in FAS-II and the elongation steps leading to the synthesis of the alpha-mycolates and oxygenated mycolates. The efficacy of TLM against M. smegmatis and M. tuberculosis provides the prospects of identifying fatty acid and mycolic acid biosynthetic genes and revealing a novel range of chemotherapeutic agents directed against M. tuberculosis.


This article has been cited by other articles:

  • Kurth, D. G., Gago, G. M., de la Iglesia, A., Bazet Lyonnet, B., Lin, T.-W., Morbidoni, H. R., Tsai, S.-C., Gramajo, H. (2009). ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria. Microbiology 155: 2664-2675 [Abstract] [Full Text]  
  • Bhowruth, V., Brown, A. K., Besra, G. S. (2008). Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636. Microbiology 154: 1866-1875 [Abstract] [Full Text]  
  • Brown, A. K., Papaemmanouil, A., Bhowruth, V., Bhatt, A., Dover, L. G., Besra, G. S. (2007). Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II. Microbiology 153: 3314-3322 [Abstract] [Full Text]  
  • Boyne, M. E., Sullivan, T. J., amEnde, C. W., Lu, H., Gruppo, V., Heaslip, D., Amin, A. G., Chatterjee, D., Lenaerts, A., Tonge, P. J., Slayden, R. A. (2007). Targeting Fatty Acid Biosynthesis for the Development of Novel Chemotherapeutics against Mycobacterium tuberculosis: Evaluation of A-Ring-Modified Diphenyl Ethers as High-Affinity InhA Inhibitors. Antimicrob. Agents Chemother. 51: 3562-3567 [Abstract] [Full Text]  
  • Parish, T., Roberts, G., Laval, F., Schaeffer, M., Daffe, M., Duncan, K. (2007). Functional Complementation of the Essential Gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but Not Escherichia coli fabG. J. Bacteriol. 189: 3721-3728 [Abstract] [Full Text]  
  • Zhang, Y.-M., White, S. W., Rock, C. O. (2006). Inhibiting Bacterial Fatty Acid Synthesis. J. Biol. Chem. 281: 17541-17544 [Abstract] [Full Text]  
  • Bhatt, A., Kremer, L., Dai, A. Z., Sacchettini, J. C., Jacobs, W. R. Jr (2005). Conditional Depletion of KasA, a Key Enzyme of Mycolic Acid Biosynthesis, Leads to Mycobacterial Cell Lysis. J. Bacteriol. 187: 7596-7606 [Abstract] [Full Text]  
  • Brown, A. K., Sridharan, S., Kremer, L., Lindenberg, S., Dover, L. G., Sacchettini, J. C., Besra, G. S. (2005). Probing the Mechanism of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Synthase III mtFabH: FACTORS INFLUENCING CATALYSIS AND SUBSTRATE SPECIFICITY. J. Biol. Chem. 280: 32539-32547 [Abstract] [Full Text]  
  • Zimhony, O., Vilcheze, C., Jacobs, W. R. Jr. (2004). Characterization of Mycobacterium smegmatis Expressing the Mycobacterium tuberculosis Fatty Acid Synthase I (fas1) Gene. J. Bacteriol. 186: 4051-4055 [Abstract] [Full Text]  
  • Betts, J. C., McLaren, A., Lennon, M. G., Kelly, F. M., Lukey, P. T., Blakemore, S. J., Duncan, K. (2003). Signature Gene Expression Profiles Discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-Treated Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47: 2903-2913 [Abstract] [Full Text]  
  • Kremer, L., Dover, L. G., Morbidoni, H. R., Vilcheze, C., Maughan, W. N., Baulard, A., Tu, S.-C., Honore, N., Deretic, V., Sacchettini, J. C., Locht, C., Jacobs, W. R. Jr., Besra, G. S. (2003). Inhibition of InhA Activity, but Not KasA Activity, Induces Formation of a KasA-containing Complex in Mycobacteria. J. Biol. Chem. 278: 20547-20554 [Abstract] [Full Text]  
  • Douglas, J. D., Senior, S. J., Morehouse, C., Phetsukiri, B., Campbell, I. B., Besra, G. S., Minnikin, D. E. (2002). Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity. Microbiology 148: 3101-3109 [Abstract] [Full Text]  
  • Iseman, M.D. (2002). Tuberculosis therapy: past, present and future. Eur Respir J 20: 87S-94s [Abstract] [Full Text]  
  • Jackowski, S., Zhang, Y.-M., Price, A. C., White, S. W., Rock, C. O. (2002). A Missense Mutation in the fabB ({beta}-Ketoacyl-Acyl Carrier Protein Synthase I) Gene Confers Thiolactomycin Resistance to Escherichia coli. Antimicrob. Agents Chemother. 46: 1246-1252 [Abstract] [Full Text]  
  • Boshoff, H. I., Mizrahi, V., Barry, C. E. III (2002). Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I. J. Bacteriol. 184: 2167-2172 [Abstract] [Full Text]  
  • Schaeffer, M. L., Agnihotri, G., Volker, C., Kallender, H., Brennan, P. J., Lonsdale, J. T. (2001). Purification and Biochemical Characterization of the Mycobacterium tuberculosisbeta -Ketoacyl-acyl Carrier Protein Synthases KasA and KasB. J. Biol. Chem. 276: 47029-47037 [Abstract] [Full Text]  
  • Schujman, G. E., Choi, K.-H., Altabe, S., Rock, C. O., de Mendoza, D. (2001). Response of Bacillus subtilis to Cerulenin and Acquisition of Resistance. J. Bacteriol. 183: 3032-3040 [Abstract] [Full Text]  
  • Parrish, N. M., Houston, T., Jones, P. B., Townsend, C., Dick, J. D. (2001). In Vitro Activity of a Novel Antimycobacterial Compound, N-Octanesulfonylacetamide, and Its Effects on Lipid and Mycolic Acid Synthesis. Antimicrob. Agents Chemother. 45: 1143-1150 [Abstract] [Full Text]  
  • Marrakchi, H., Lanéelle, G., Quémard, A. (2000). InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 146: 289-296 [Abstract] [Full Text]  
  • Phetsuksiri, B., Baulard, A. R., Cooper, A. M., Minnikin, D. E., Douglas, J. D., Besra, G. S., Brennan, P. J. (1999). Antimycobacterial Activities of Isoxyl and New Derivatives through the Inhibition of Mycolic Acid Synthesis. Antimicrob. Agents Chemother. 43: 1042-1051 [Abstract] [Full Text]  
  • Parrish, N. M., Kuhajda, F. P., Heine, H. S., Bishai, W. R., Dick, J. D. (1999). Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis. J Antimicrob Chemother 43: 219-226 [Abstract] [Full Text]  
  • Telenti, A (1998). Genetics and pulmonary medicine bullet  5: Genetics of drug resistant tuberculosis. Thorax 53: 793-797 [Full Text]  
  • Schweizer, H. P. (1998). Intrinsic Resistance to Inhibitors of Fatty Acid Biosynthesis in Pseudomonas aeruginosa Is Due to Efflux: Application of a Novel Technique for Generation of Unmarked Chromosomal Mutations for the Study of Efflux Systems. Antimicrob. Agents Chemother. 42: 394-398 [Abstract] [Full Text]  
  • Belisle, J. T., Vissa, V. D., Sievert, T., Takayama, K., Brennan, P. J., Besra, G. S. (1997). Role of the Major Antigen of Mycobacterium tuberculosis in Cell Wall Biogenesis. Science 276: 1420-1422 [Abstract] [Full Text]  
  • Kremer, L., Douglas, J. D., Baulard, A. R., Morehouse, C., Guy, M. R., Alland, D., Dover, L. G., Lakey, J. H., Jacobs, W. R. Jr., Brennan, P. J., Minnikin, D. E., Besra, G. S. (2000). Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes in Mycobacterium tuberculosis. J. Biol. Chem. 275: 16857-16864 [Abstract] [Full Text]  
  • Choi, K.-H., Kremer, L., Besra, G. S., Rock, C. O. (2000). Identification and Substrate Specificity of beta -Ketoacyl (Acyl Carrier Protein) Synthase III (mtFabH) from Mycobacterium tuberculosis. J. Biol. Chem. 275: 28201-28207 [Abstract] [Full Text]  
  • Price, A. C., Choi, K.-H., Heath, R. J., Li, Z., White, S. W., Rock, C. O. (2001). Inhibition of beta -Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin. STRUCTURE AND MECHANISM. J. Biol. Chem. 276: 6551-6559 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»